Ngā hua rapu - Chavez JC

Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell Lymphoma mā Castaneda-Puglianini O, Chavez JC

Whiwhi kuputuhi katoa

Axicabtagene Ciloleucel in the Management of Follicular Lymphoma: Current Perspectives on Clinical Utility, Patient Selection and Reported Outcomes mā Mohty R, Kharfan-Dabaja MA, Chavez JC

Whiwhi kuputuhi katoa

Axicabtagene ciloleucel (KTE-C19), an anti-CD19 CAR T therapy for the treatment of relapsed/refractory aggressive B-cell non-Hodgkin’s lymphoma mā Jain MD, Bachmeier CA, Phuoc VH, Chavez JC

Whiwhi kuputuhi katoa

Cytokine Release Syndrome: Current Perspectives mā Murthy H, Iqbal M, Chavez JC, Kharfan-Dabaja MA

Whiwhi kuputuhi katoa